3 ms·
My understanding is that the only reason this worked for mRNA is that it was basically already at the end point of the development cycle of figuring out which d
by vlovich123 5y ago
My understanding is that the only reason this worked for mRNA is that it was basically already at the end point of the development cycle of figuring out which disease to apply it to. It was just waiting for patients to demonstrate efficacy and safety. COVID-19 provided that opportunity. This is not a repeatable model for other new technologies though. Now that mRNA safety has been proven out, the hurdles to applying it to other things are drastically reduced (as they would have been once the first mRNA drug got approved).
Similarly, having a ready population pool and an urgent need is not likely to come up again although maybe mRNA drugs in general have a safety profile that might warrant giving them to patients who have no other alternative.